Valuation: Forian Inc.

Market Cap 67.79M 59.12M 55.82M 50.69M 94.97M 6.51B 95.36M 669M 258M 3.31B 255M 249M 10.64B P/E 2024
-17x
P/E 2025 -22.9x
Enterprise Value 36.25M 31.61M 29.85M 27.11M 50.79M 3.48B 51M 358M 138M 1.77B 136M 133M 5.69B EV / Sales 2024
1.76x
EV / Sales 2025 1.13x
Free-Float
56.66%
Yield 2024 *
-
Yield 2025 -
1 day+0.46%
6 months+4.33%
Current year+2.36%
Current year 2.01
Extreme 2.01
2.2
1 year 2.01
Extreme 2.01
2.62
3 years 1.64
Extreme 1.64
4.15
5 years 1.64
Extreme 1.64
11.38
10 years 1.64
Extreme 1.64
45
Manager TitleAgeSince
Corporate Officer/Principal 60 15/10/2020
Chief Executive Officer 38 10/02/2023
Director of Finance/CFO 64 02/09/2021
Director TitleAgeSince
Chairman 38 15/10/2020
Date Insider Type Main position Quantity % Market Cap. Importance
15/05/26 Issuer sale

Founder

-1,528,927 4.9142%
15/05/26 Issuer sale

Director

-251,184 0.8073%
15/05/26 Tender

Director

-85,000 0.2732%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%-.--%-6.06%-1.36% 67.79M
+0.72%-2.40%-7.76%+27.61% 42.13B
-2.36%+0.10%-48.27%+128.78% 12.59B
-1.80%-4.29%-11.18%+105.11% 5.65B
+0.01%+1.96%+60.71% - 4.41B
+1.17%+7.69% - - 2.2B
+0.39%-3.51%+2.26%-36.67% 1.47B
+3.45%+3.29%-34.10% - 1.03B
+1.10%-1.75%+13.77%+153.27% 991M
+3.94%+3.26%+40.42%+53.25% 913M
Average +0.66%+1.38%+1.09%+61.42% 7.15B
Weighted average by Cap. +0.00%+0.51%-10.28%+55.24%

Financials

2024 2025
Net sales 20.15M 17.57M 16.59M 15.07M 28.23M 1.93B 28.35M 199M 76.7M 983M 75.71M 74.02M 3.16B 30.26M 26.38M 24.91M 22.62M 42.39M 2.9B 42.56M 298M 115M 1.48B 114M 111M 4.75B
Net income -3.77M -3.29M -3.1M -2.82M -5.28M -362M -5.3M -37.19M -14.35M -184M -14.17M -13.85M -592M -2.87M -2.51M -2.37M -2.15M -4.03M -276M -4.04M -28.35M -10.94M -140M -10.8M -10.56M -451M
Net Debt -28.35M -24.72M -23.34M -21.2M -39.71M -2.72B -39.88M -280M -108M -1.38B -106M -104M -4.45B -31.54M -27.5M -25.97M -23.58M -44.18M -3.03B -44.37M -311M -120M -1.54B -118M -116M -4.95B
Logo Forian Inc.
Forian Inc. is a healthtech company. It is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. It provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers within the healthcare and life sciences and financial services industries. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its solutions include CHRONOS, Chartis, real-world evidence (RWE) and Kyber Data Science. CHRONOS combines open and closed claims, electronic health records, and social determinants of health data into a single, integrated model. It also provides researchers access to healthcare payers, providers, and clinical data with non-traditional healthcare sources, such as social determinants of health (SDoH) data, to uncover novel insights.
Employees
50
  1. Stock Market
  2. Stocks
  3. FORA Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!